Fingerprint
Dive into the research topics of 'A phase I/II study combining erlotinib and dasatinib for non-small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I/II study combining erlotinib and dasatinib for non-small cell lung cancer
Kathryn A. Gold, J. Jack Lee, Nusrat Harun, Ximing Tang, Justina Price, Jitesh D. Kawedia, Hai T. Tran, Jeremy J. Erasmus, George R. Blumenschein, William N. William, Ignacio I. Wistuba, Faye M. Johnson
Research output: Contribution to journal › Article › peer-review
35
Scopus
citations